SCHEMBL31669332

SCHEMBL31669332

N[C@@H]1CCN(c2ccc(Br)cc2Cl)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HTT P42858 1/20 0.43
NOTUM Q6P988 4/20 0.42
PIM1 P11309 2/20 0.40
PIM3 Q86V86 2/20 0.40
PIM2 Q9P1W9 2/20 0.40
AKT1 P31749 1/20 0.39
HRH4 Q9H3N8 3/20 0.38
MAT2A P31153 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
POLB P06746 1/20 0.37
CCR5 P51681 1/20 0.36
PTPN11 Q06124 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
MEN1 O00255 1/20 0.36
HTR3B O95264 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1514235 0.81 DPP4 (0.40) HTR3AHRH4
SCHEMBL12835675 0.81 DPP4 (0.40) HTR3AHRH4
Hydrochloric Acid SCHEMBL1514498 0.80 DPP4 (0.39) HTR3AHRH4
SCHEMBL27125945 0.79 HTR3A (0.48) HTR3AALDH1A1HTTNOTUMPIM1
SCHEMBL27125938 0.79 HTR3A (0.48) HTR3AALDH1A1HTTNOTUMPIM1
SCHEMBL23708584 0.78 GAA (0.48) ALDH1A1HTTIRAK4MEN1ALOX15
SCHEMBL31318672 0.77 ALDH1A1 (0.43) HTR3AALDH1A1HTTNOTUMHRH4
SCHEMBL22186838 0.77 IDH2 (0.43) ALDH1A1HTTNOTUMHRH4MEN1
SCHEMBL9939917 0.77 HRH4 (0.43) HTR3AALDH1A1HTTNOTUMPIM1
Hydrochloric Acid SCHEMBL28919352 0.76 IDH2 (0.43) ALDH1A1HTTNOTUMHRH4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 HTR3A 2372/4885ALDH1A1 3864/4885HTT 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.